Promega to Showcase Applications of Bioluminescent Research Tools at Global Seminar Series
Promega will demonstrate applications of bioluminescence tools at Discover Glo 2021.
Promega Corporation announced that it will showcase various applications of bioluminescence research tools at their Discover Glo 2021 conference, a virtual event which will be held Sept. 13–16, 2021.
The aim of the conference is to advance understanding in key therapeutic areas, such as targeted protein degradation and kinase biology. Each day will feature discussions focusing on a topic surrounding luciferase technologies.
These daily topics include:
- Bioluminescence: Past, Present, Future (Sept. 13)
- Applications of CRISPR Knock-in Tagging for Studying Endogenous Protein Dynamics (Sept. 14)
- Understanding Kinase Target Engagement in Live Cells (Sept. 15)
- Advances in Targeted Protein Degradation (Sept. 16)
Prominent speakers from various related fields will be in attendance. For a full list of these individuals, the company press release can be found here.
Source: Promega
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
In Wake of Trump Tariffs, Lilly Plans New US Pharmaceutical Manufacturing Sites
February 26th 2025Previous domestic capital expansion commitments since 2020 had been made in Research Triangle Park and Concord, both in North Carolina; Kenosha County, Wisconsin; Lebanon, Indiana; and Lilly’s home city of Indianapolis.
Cosette Pharmaceuticals Adds to Dermatology and Women’s Health Portfolio with Mayne Pharma Purchase
Published: February 26th 2025 | Updated: February 26th 2025While the boards of directors of both companies have approved the transaction, it is not expected to close until the second quarter of 2025, as Mayne Pharma’s shareholders must still vote in favor of the acquisition.
